Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romipl...
Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab)
Buyer
Servicio Cántabro de Salud
Value
€64,220,069
Published
24 Sept 2026
Closes
Not provided
Procurement details
Source
TED (EU)
Region
ES130
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot LOT-0001 Lote 1. Blincyto (Blinatumomab)
€5,538,480
Lote 1. Blincyto (Blinatumomab)
Delivery: ES130 · Spain
Lot LOT-0002 Lote 3. Lumykras (Sotorasib)
€2,045,952
Lote 3. Lumykras (Sotorasib)
Delivery: ES130 · Spain
Lot LOT-0003 Lote 4. Nplate (Romiplostim)
€1,862,402
Lote 4. Nplate (Romiplostim)
Delivery: ES130 · Spain
Lot LOT-0004 Lote 5. Parsabiv (Etelcalcetida Hidrocloruro)
€2,934,144
Lote 5. Parsabiv (Etelcalcetida Hidrocloruro)
Delivery: ES130 · Spain
Lot LOT-0005 Lote 7. Uplizna (Inebilizumab)
€7,992,000
Lote 7. Uplizna (Inebilizumab)
Delivery: ES130 · Spain
Lot LOT-0006 Lote 8. Vectibix (Panitumumab)
€5,954,410
Lote 8. Vectibix (Panitumumab)
Delivery: ES130 · Spain
Documents
Unlock document linkTED notice 657935-2026
24 Sept 2026
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.